On Jan. 26, the Food and Drug Administration (FDA) will hold a VRBPAC meeting to discuss whether and how the composition for primary doses of COVID-19 vaccines should be modified. The committee is also scheduled to discuss how and whether the composition and schedule for booster doses should be adjusted moving forward.
Additional information can be found in FDA’s News Release: Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting to Discuss Future Vaccination Regimens Addressing COVID-19.
Beginning the week of Jan. 6, Pfizer’s COVID-19 Vaccine Immunization Site Training webinars will transition from live events to ON DEMAND content for all health care providers.
LIVE sessions will still occur, as needed, to address new vaccine information so visit Pfizer and BioNTech’s COVID-19 Vaccines Training Resources frequently for the latest schedule and to access webinars.
|